Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing (with photos)
******************************************************************************************
In his address at the opening ceremony, Professor Lo said, "Hong Kong and the Mainland have a long-standing collaboration in hepatobiliary surgery. I have personally witnessed experts from both places jointly performing a number of complex liver transplant surgeries, achieving in-depth integration of technology and resources, which is an exemplary model of medical co-operation under the 'one country, two systems' framework. In recent years, Hong Kong and the Mainland have also made breakthroughs in organ donation and transplantation. In December 2022 and February this year, two cases of cross-boundary heart donation successfully saved the lives of two infants, exemplifying to the fullest the inseparable ties between the Mainland and Hong Kong as well as our shared principle and mission in protecting and saving lives. With the accumulation of experience, the channels and procedures for handling urgent cross-boundary organ transplant requests have now been streamlined and standardised. The HKSAR Government will continue to explore arrangements for regularising this mechanism."
He also shared the latest developments in the prevention and control of liver disease in Hong Kong. He said, "Since 1988, Hong Kong has provided universal hepatitis B vaccination for all newborns, significantly reducing infection rates among younger generations. As outlined in last year's Policy Address, the Chief Executive also proposed to implement hepatitis B screening to prevent liver cancer. If patients can be identified at an early stage, it will facilitate 'early identification and early treatment', thereby effectively reducing risks of developing complications including cirrhosis and liver cancer."
The conference was jointly organised by the Jiangsu Anti-cancer Association, the Jiangsu Medical Doctor Association, and the Jiangsu Medical Association. The conference brought together international experts and scholars in liver disease, as well as senior health officials from around the world.
Professor Lo then visited the Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), where he exchanged views and shared experiences on enhancing hospital management and services with the President of Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), Professor Liu Yun. He said, "The Hospital Authority (HA) is adopting China's International Hospital Accreditation Standards (2021 Version) developed by the Shenzhen Hospital Accreditation Research Centre to resume the hospital accreditation programme at its public hospitals. Through independent professional hospital accreditation organisations, various aspects of hospital performance are assessed in an objective manner, with a view to enhancing the quality of healthcare institutions and safeguarding patient safety. Moreover, the HA seeks to optimise the diagnosis process of the relevant specialties and improve the treatment outcomes through the establishment of the first stroke centre at Tuen Mun Hospital, as well as chest pain centres at both Queen Mary Hospital and Prince of Wales Hospital in accordance with national accreditation standards, thereby enhancing the survival rate of patients."
Professor Lo added, "The HKSAR Government will continue to promote the accreditation programme under the Standards as well as the establishment of chest pain centres and stroke centres. These initiatives will not only improve healthcare integration within the Guangdong-Hong Kong-Macao Greater Bay Area and support Hong Kong's integration into national development, but also leverage Hong Kong's advantages of enjoying strong support of the motherland and being closely connected to the world, so as to demonstrate the excellence of the national hospital accreditation standards to the international community."
The Assistant Director of Health (Drug), Mr Frank Chan; the Director (Quality and Safety) of the HA, Dr Michael Wong, and the Cluster Chief Executive of Hong Kong West Cluster of the HA, Dr Theresa Li, accompanied Professor Lo to attend today's functions. They will return to Hong Kong this afternoon.
Ends/Saturday, July 12, 2025
Issued at HKT 12:04
Issued at HKT 12:04
NNNN
Photo
